As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...